Elbasvir
10 interactions 2 explained in plain English
Medically reviewed by
Dr. Brian Staiger, PharmD, BCPS
· Updated Jul 4, 2026
· Editorial policy
· Data sources
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Most serious with:
Abametapir
Alpelisib
Atogepant
Atorvastatin
Ketoconazole Topical
Letermovir Injection
Major
Elbasvir Abametapir Explained Increased exposure of CYP3A4 substrate Details Elbasvir Alpelisib Piqray Increased alpelisib exposure and an increased risk of alpelisib-related adverse effects and toxicity Details Elbasvir Atogepant Qulipta Increased atogepant exposure Details Elbasvir Atorvastatin Atorvaliq Increased atorvastatin exposure and an increased risk of myopathy and rhabdomyolysis Details Elbasvir Ketoconazole Topical Extina® Foam Increased elbasvir exposure and an increase elbasvir-related adverse reactions Details Elbasvir Letermovir Injection Prevymis Increased CYP3A substrate exposure Details Elbasvir Nafcillin Injection Unipen® Injection Decreased elbasvir plasma concentrations and reduced elbasvir efficacy DetailsModerate
Elbasvir Simvastatin Flolipid Explained Increased statin plasma concentrations Details Elbasvir Fluvastatin Lescol Increased statin plasma concentrations Details Elbasvir Lovastatin Altocor® Increased statin plasma concentrations DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacistEducational information only, not medical advice. Always confirm interactions with your pharmacist
or prescriber before making any change to your medications.